Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Langdon

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Leukemia Research|January 1, 1988
Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamideS P Langdon, F M Richards, J A Hickman
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1994
Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatographyJ Cummings, A MacLellan, S P Langdon, et al.
Biochemical Pharmacology|April 1, 1984
Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolismD Ross, S P Langdon, A Gescher, et al.
International Journal of Cancer|September 17, 1996
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell linesP Mullen, A Ritchie, S P Langdon, et al.
British Journal of Cancer|May 29, 2014
Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancerA Koussounadis, S P Langdon, D J Harrison, et al.
General Pharmacology|February 1, 1997
Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcomaS P Langdon, A Gescher, J A Hickman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combinationE S Harpur, S P Langdon, S A Fathalla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell linesA J Crew, S P Langdon, E P Miller, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Leukemia Research|January 1, 1988
Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamideS P Langdon, F M Richards, J A Hickman
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1994
Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatographyJ Cummings, A MacLellan, S P Langdon, et al.
Biochemical Pharmacology|April 1, 1984
Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolismD Ross, S P Langdon, A Gescher, et al.
International Journal of Cancer|September 17, 1996
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell linesP Mullen, A Ritchie, S P Langdon, et al.
British Journal of Cancer|May 29, 2014
Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancerA Koussounadis, S P Langdon, D J Harrison, et al.
General Pharmacology|February 1, 1997
Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcomaS P Langdon, A Gescher, J A Hickman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combinationE S Harpur, S P Langdon, S A Fathalla, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell linesA J Crew, S P Langdon, E P Miller, et al.
Pageof 8